Side effects of Levodopa

Levodopa is the precursor to dopamine. Most commonly, clinicians use levodopa as a dopamine replacement agent for the treatment of Parkinson's disease. It is most effectively used to control bradykine

Jan 17,2022  API

Different synthetic routes to vortioxetine hydrobromide

Vortioxetine hydrobromide is an atypical antidepressant made by Lundbeck and Takeda.

Jan 17,2022  API

The characteristic and application of maltodextrin

Maltodextrin is a polysaccharide produced from starch by partial enzymatic hydrolysis of starch.

Jan 17,2022  API

The property and application of dimethicone

Dimethicone is a fluid mixture of fully methylated linear siloxane polymers end-blocked with trimethylsiloxy units.

Jan 17,2022  API

Introduction of D-glucose

Anhydrous Dextrose is the anhydrous form of D-glucose, a natural monosaccharide and carbohydrate. Dextrose serves to replenish lost nutrients and electrolytes.

Jan 17,2022  Drugs

Introduction of Aluminum chloride

Aluminum chloride is an inorganic substance with the chemical formula AlCl3.

Jan 17,2022  Inorganic salts

Uses of Diazoxide

Diazoxide is a well-characterized low molecular weight (MW 230.7) drug that is a derivative of benzothiadiazine but that possesses antidiuretic effects. It has been approved and used since the 1970s f

Jan 17,2022  API

Uses of Diazoaminobenzene

Diazoaminobenzene (DAAB) is an aromatic amine that is a suspected carcinogen. It is harmful if inhaled, ingested, or absorbed through the skin. It causes skin irritation and severe irritation to eyes.

Jan 17,2022  Organic Chemistry

Synthesize of Diacetyl

Diacetyl is a water-soluble and volatile, alpha-diketone compound that has a buttery odor. Diacetyl occurs naturally in plants, fruits, coffee, honey, cocoa, and dairy products. It is a natural by-pro

Jan 17,2022  Organic Chemistry

Toxicity of Dextromethorphan

Dextromethorphan is in the morphinan class of medications with dissociative, and stimulant properties (at lower doses). Dextromethorphan does not have a significant affinity for the mu-opioid receptor

Jan 17,2022  API
Prev12345678910...Next>  Go to Page